Morning Breakouts

Latest KFF Health News Stories

EpiPen Maker Reportedly Offered States Discounts If They Cut Down Competition

Morning Briefing

Stat reports that Mylan made the rebates conditional on states requiring that competitors’ products get special requests by clinicians to be covered by Medicaid. In other news, the Food and Drug Administration says it will hold a hearing on efforts by drugmakers to impede competition, and an Australian drug company that is linked to a U.S. congressman gets approval for U.S. trials.